SpeechATAXIA- a multinational, multilanguage consortia for speech in hereditary ataxias – powered by Redenlab

Redenlab is supporting a new speech focussed consortium for ataxia. SpeechATAXIA is a multi-language, multi-national, multi-ataxia study measuring communication change. Participants are recruited from investigator sites in Australia, New Zealand, Europe, North and South America.

The consortia goals include:
Precisely describe longitudinal changes occurring in speech as disease progresses,
– Identify predictors of progression and discover if critical milestones exist in the disease course,
– Explore how communication decline shapes quality of life and disease management,
– Strengthen genotype-phenotype associations to create disease specific profiles.

The program of research is supported by the Ataxia Global Initiative.

Related Post

  • Posted on 30 March, 2023
    Ataxia telangiectasia (A-T) is a rare inherited condition that affects the nervous and immune systems. A-T typically impacts movement, vision...
    • Posted on 10 March, 2023
      Speech is a cardinal and important feature of ataxia. We have put together a comprehensive description of dysarthria in spinocerebellar...
      • Posted on 10 March, 2023
        The paper describes the outcomes from a clinical trial for Friedreich ataxia (the most common hereditary ataxia impacting walking, talking,...